, Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, International Journal of Cancer, vol.13, issue.5, pp.359-386, 2015.
DOI : 10.1016/S1470-2045(12)70137-7
, Squamous cell carcinoma of the head and neck in never smoker???never drinkers: A descriptive epidemiologic study, Head & Neck, vol.8, issue.1, pp.75-84, 2008.
DOI : 10.1136/bmj.313.7059.716
, Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States, Journal of Clinical Oncology, vol.29, issue.32, pp.4294-4301, 2011.
DOI : 10.1200/JCO.2011.36.4596
, Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas, Oral Oncology, vol.49, issue.1, pp.1-8, 2013.
DOI : 10.1016/j.oraloncology.2012.07.002
, Increasing Incidence of Oral Tongue Squamous Cell Carcinoma in Young White Women, Age 18 to 44 Years, Journal of Clinical Oncology, vol.29, issue.11, pp.1488-1494, 2011.
DOI : 10.1200/JCO.2010.31.7883
, Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke, Head & Neck, vol.8, issue.11, pp.1642-1649, 2015.
DOI : 10.1016/S1074-5521(01)00019-9
, Squamous Cell Carcinoma of the Oral Tongue in Young Non-Smokers Is Genomically Similar to Tumors in Older Smokers, Clinical Cancer Research, vol.20, issue.14, pp.3842-3848, 2014.
DOI : 10.1158/1078-0432.CCR-14-0565
, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium Head and neck cancer in nonsmokers: a distinct clinical and molecular entity The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor Types The promise of immunostimulatory antibodies in head and neck cancer Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial The promise of immunotherapy in head and neck squamous cell carcinoma, Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck, pp.777-789, 1999.
, Cigarette smoking and inflammation: cellular and molecular mechanisms Tobacco smoke-induced immunologic changes may contribute to oral carcinogenesis, J Dent Res J Investig Med, vol.91, issue.62, pp.142-149, 2012.
, Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer, Metastasis, Immune Response, and Host Survival, pp.2117-2123, 2006.
DOI : 10.1093/annonc/mdw319
, A gene expression profile for non-smoking and non-drinking patients with head and neck cancer Vigneron N, van Baren N, Van den Eynde BJ. Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance, 24. Vacchelli E, Aranda F, Eggermont A et al. Trial watch: IDO inhibitors in cancer therapy, pp.178-183, 2012.
, Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma, Cell, vol.165, issue.1, pp.35-44, 2016.
DOI : 10.1016/j.cell.2016.02.065
, Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck Cancer immunotherapy: the beginning of the end of cancer Comprehensive genomic characterization of head and neck squamous cell carcinomas Antitumor Activity of Pembrolizumab in Biomarker- Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort, 30. Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy, pp.61-69, 2015.
, Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade, Cancer Discovery, vol.6, issue.8, 2016.
DOI : 10.1158/2159-8290.CD-15-1545